Position in VERA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,539,113
-$707,264 QoQ
Shares Held
63,115
-1.5% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 9.650637724788085.ToString("F0")%
Shared 0.ToString("F0")%
None 90.34936227521192.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. VERA ranks #133 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in VERA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,539,113 | 63,115 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $3,246,377 | 64,107 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,393,525 | 82,365 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $7,316,485 | 310,547 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,146,761 | 47,742 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,366,599 | 221,485 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,705,997 | 129,095 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $4,839,942 | 133,774 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $14,469,517 | 335,564 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $482,084 | 31,345 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $316,166 | 23,061 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $421,006 | 26,231 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $129,141 | 16,642 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $2,205,550 | 113,982 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,605,281 | 75,330 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,346,517 | 98,936 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,514,127 | 149,601 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,034,086 | 76,126 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,364,612 | 78,652 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||